Related Experiment Videos

Coronary vasospasm as a pathogenetic mechanism of coronary heart disease

Medecine Interne
|January 1, 1980
PubMed

Insights

Coronary vasospasm, a key factor in coronary heart disease, involves artery structure and nervous system control. This review explores its role and the impact of medications on vasospasm.

Area of Science:

  • Cardiology
  • Pathophysiology
  • Vascular Biology

Background:

  • Coronary heart disease (CHD) is a leading cause of mortality worldwide.
  • Understanding the pathogenetic mechanisms of CHD is crucial for effective treatment.
  • Coronary vasospasm is increasingly recognized as a significant contributor to CHD.

Purpose of the Study:

  • To review current knowledge on coronary vasospasm as a pathogenetic mechanism in CHD.
  • To explore the relationship between coronary artery microarchitecture and vasospasm.
  • To examine the role of nervous system control in coronary artery spasm.
  • To discuss the clinical manifestations of CHD related to vasospasm.
  • To summarize the effects of pharmacological interventions on coronary vasospasm.

Main Methods:

  • Literature review of recent available information.
  • Synthesis of data on coronary artery microarchitecture and spasm.
  • Analysis of studies on neural control of coronary arteries.
  • Examination of clinical data linking vasospasm to CHD manifestations.
  • Review of pharmacological data on anti-vasospasm drugs.

Main Results:

  • Coronary vasospasm is intricately linked to the coronary artery's microarchitectural features.
  • Nervous system modulation significantly influences coronary artery spasm.
  • Vasospasm is associated with diverse clinical presentations of coronary heart disease.
  • Various drugs demonstrate efficacy in modulating or preventing coronary vasospasm.

Conclusions:

  • Coronary vasospasm is a critical pathogenetic mechanism in coronary heart disease.
  • Understanding the interplay between microarchitecture, neural control, and vasospasm is vital.
  • Pharmacological management targeting coronary vasospasm holds therapeutic potential for CHD patients.

Related Concept Videos